VON WILLEBRAND FACTOR PREDICTS RESPONSE TO MEDICAL THERAPY OF PORTAL HYPERTENSION

被引：0
|
作者：
Homoncik, M. [1 ]
Ferlitsch, A. [1 ]
Reiberger, T. [1 ]
Ulbrich, G. [1 ]
Gangl, A. [1 ]
Peck-Radosavljevic, M. [1 ]
机构：
[1] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 50卷
关键词：
D O I：
10.1016/S0168-8278(09)60197-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
195
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [1] Von Willebrand factor predicts clinically significant portal hypertension in patients with liver cirrhosis
    Homoncik, M.
    Ferlitsch, A.
    Reiberger, T.
    Ulbrich, G.
    Gangl, A.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S114 - S115
  • [2] Von Willebrand factor antigen predicts portal hypertensive bleeding, infections, and survival, independently of portal hypertension severity
    Mandorfer, M.
    Schwabl, P.
    Bucsics, T.
    Paternostro, R.
    Pomej, K.
    Thaler, J.
    Ay, C.
    Quehenberger, P.
    Trauner, M.
    Peck-Radosavljevic, M.
    Reiberger, T.
    Ferlitsch, A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S373 - S374
  • [3] von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis
    Georgios N Kalambokis
    Gerasimos Baltayiannis
    Dimitrios Christodoulou
    World Journal of Gastroenterology, 2016, (19) : 4786 - 4788
  • [4] von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis
    Kalambokis, Georgios N.
    Baltayiannis, Gerasimos
    Christodoulou, Dimitrios
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (19) : 4786 - 4788
  • [5] Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity
    Mandorfer, M.
    Schwabl, P.
    Paternostro, R.
    Pomej, K.
    Bauer, D.
    Thaler, J.
    Ay, C.
    Quehenberger, P.
    Fritzer-Szekeres, M.
    Peck-Radosavljevic, M.
    Trauner, M.
    Reiberger, T.
    Ferlitsch, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (07) : 980 - 988
  • [6] Transient elastography and von Willebrand factor as predictors of portal hypertension and decompensation in children
    Goel, Akshat
    Hegarty, Robert
    Dixit, Shweta
    Tucker, Bethany
    Douiri, Abdel
    Kyrana, Eirini
    Jain, Vandana
    Dhawan, Anil
    Grammatikopoulos, Tassos
    JHEP REPORTS, 2023, 5 (12)
  • [7] Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status
    Lee, Adrienne
    Sinclair, Gary
    Valentine, Karen
    James, Paula
    Poon, Man-Chiu
    BLOOD, 2014, 124 (05) : E1 - E3
  • [8] Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension
    La Mura, Vincenzo
    Carlos Reverter, Juan
    Flores-Arroyo, Alexandra
    Raffa, Sebastian
    Reverter, Enric
    Seijo, Susana
    Abraldes, Juan G.
    Bosch, Jaime
    Carlos Garcia-Pagan, Juan
    GUT, 2011, 60 (08) : 1133 - 1138
  • [9] von Willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: a systematic review and meta-analysis
    Zou, Ziyuan
    Yan, Xinwen
    Li, Cheng
    Li, Xiaofeng
    Ma, Xiaofen
    Zhang, Chunqing
    Ju, Shenghong
    Tian, Junzhang
    Qi, Xiaolong
    BMJ OPEN, 2019, 9 (08):
  • [10] VON WILLEBRAND FACTOR LEVELS CORRELATE WITH THE SEVERITY OF PORTAL HYPERTENSION AND INDEPENDENTLY PREDICT THE CLINICAL OUTCOME OF CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION
    La Mura, V.
    Reverter, J. C.
    Flores-Arroyo, A.
    Hernandez-Guerra, M.
    Abraldes, J. G.
    Garcia-Pagan, J. C.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S75 - S76
12345